Publication | Closed Access

P-497 ZD6474 in combination with carboplatin and paclitaxel as first-line treatment in patients with NSCLC: Results of the run-in phase of a two-part randomized Phase II study

OncologyPharmacologyClinical TrialsP-497 Zd6474First-line TreatmentPharmacotherapyAnti-cancer AgentRun-in PhaseCancer TreatmentMedicineLung Cancer